Literature DB >> 9092484

The content of intracellular mitochondrial DNA is decreased by 1-methyl-4-phenylpyridinium ion (MPP+).

K Miyako1, Y Kai, T Irie, K Takeshige, D Kang.   

Abstract

1-Methyl-4-phenylpyridinium ion (MPP+), an oxidative metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), is considered to be directly responsible for MPTP-induced Parkinson's disease-like symptoms by inhibiting NADH-ubiquinone oxidoreductase (complex I) in the mitochondrial respiratory chain. Here we demonstrate that 25 microM MPP+ decreases the content of mitochondrial DNA to about one-third in HeLa S3 cells. On the contrary, 0.1 microM rotenone, which inhibits complex I to the same extent as 25 microM MPP+ in the cells, increases the content of mitochondrial DNA about 2-fold. Hence, the effect of MPP+ on mitochondrial DNA is not mediated by the inhibition of complex I. To examine the replication state of mitochondrial DNA, we measured the amount of nascent strands of mitochondrial DNA. The amount is decreased by MPP+ but increased by rotenone, suggesting that the replication of mitochondrial DNA is inhibited by MPP+. Because the proper amount of mitochondrial DNA is essential to maintain components of the respiratory chain, the decrease of mitochondrial DNA may play a role in the progression of MPTP-induced Parkinson's disease-like symptoms caused by the mitochondrial respiratory failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092484     DOI: 10.1074/jbc.272.15.9605

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Age related somatic mitochondrial DNA deletions in bone.

Authors:  S S Papiha; H Rathod; I Briceno; J Pooley; H K Datta
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

2.  Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.

Authors:  X R Pan-Zhou; L Cui; X J Zhou; J P Sommadossi; V M Darley-Usmar
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Ditercalinium chloride, a pro-anticancer drug, intimately associates with mammalian mitochondrial DNA and inhibits its replication.

Authors:  Mayumi Okamaoto; Takashi Ohsato; Kazuto Nakada; Kotoyo Isobe; Johannes N Spelbrink; Jun-Ichi Hayashi; Naotaka Hamasaki; Dongchon Kang
Journal:  Curr Genet       Date:  2003-04-05       Impact factor: 3.886

4.  Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes.

Authors:  J Y Chen; G C Tsao; Q Zhao; W Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2001-09-01       Impact factor: 4.219

5.  Analysis of Human Mitochondrial DNA Content by Southern Blotting and Nonradioactive Probe Hybridization.

Authors:  Joel H Wheeler; Carolyn K J Young; Matthew J Young
Journal:  Curr Protoc Toxicol       Date:  2019-04-14

6.  Regulation of mitochondrial D-loops by transcription factor A and single-stranded DNA-binding protein.

Authors:  Chihiro Takamatsu; Shuyo Umeda; Takashi Ohsato; Tetsuji Ohno; Yoshito Abe; Atsushi Fukuoh; Hideo Shinagawa; Naotaka Hamasaki; Dongchon Kang
Journal:  EMBO Rep       Date:  2002-04-18       Impact factor: 8.807

Review 7.  Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.

Authors:  Dominik Haddad; Ken Nakamura
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

8.  The epigenetic regulation of HIF-1α by SIRT1 in MPP(+) treated SH-SY5Y cells.

Authors:  Su-Yan Dong; Yan-Jie Guo; Ya Feng; Xin-Xin Cui; Sheng-Han Kuo; Te Liu; Yun-Cheng Wu
Journal:  Biochem Biophys Res Commun       Date:  2016-01-06       Impact factor: 3.575

9.  The role of mitochondria in brain aging and the effects of melatonin.

Authors:  Germaine Escames; Ana López; José Antonio García; Laura García; Darío Acuña-Castroviejo; José Joaquín García; Luis Carlos López
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 10.  The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.

Authors:  John P Alao
Journal:  Mol Cancer       Date:  2007-04-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.